ALN-AAT02
ALN-AAT02-001
Phase 2 small_molecule terminated
Quick answer
ALN-AAT02 for ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease is a Phase 2 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated